Cartalax (25mg) is a peptide complex studied for its potential to support cartilage health, enhance joint mobility, and promote regeneration of connective tissue structures.
This peptide has been shown in research to influence gene expression related to collagen synthesis and chondrocyte function, aiding in the repair and maintenance of cartilage and joint surfaces.
Unlike conventional joint supplements, Cartalax targets cellular pathways involved in connective tissue integrity, offering a more direct approach to supporting joint and musculoskeletal resilience.
Studies suggest Cartalax may help reduce inflammation, improve flexibility, and aid in the recovery of joints and tendons following physical stress or degeneration.
Ideal for focus on joint preservation, mobility enhancement, and long-term connective tissue health in models of aging, injury, or high physical demand.
Alpha Biomed is not a compounding pharmacy or chemical compounding facility as defined under 503a of the federal food, drug, and cosmetic act. Alpha Biomed is not an outsourcing facility as defined under 503b of the federal food, drug, and cosmetic act.
Choosing a selection results in a full page refresh.
